Around the world, millions of people are at an increased risk of illness or death from taking poor-quality medicines used to prevent or treat devastating illnesses. With funding from partners like the United States Agency for International Development (USAID), USP strengthens medicines quality assurance systems, increases the supply of quality-assured medicines, and develops capacity to detect and remove poor-quality medicines from the market. By sharing scientific expertise and providing technical support and leadership, we help local regulators improve and sustain local health systems, and enable manufacturers to supply quality-assured essential medicines for years to come. Through these efforts, we’re able to help prevent and treat diseases like HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases, and improve maternal, newborn and child health.
Helping to advance global health
USP staff members across four offices in Africa and the United States share what it means to them personally to advance global public health through programs such as Promoting the Quality of Medicines Plus (PQM+), funded by USAID and implemented by USP.
The Promoting the Quality of Medicines Plus (PQM+) program, helps low- and middle-income countries strengthen the systems that ensure the quality and increase the supply of priority medicines. Funded by USAID, the PQM+ program is implemented by USP.
- USP and DFAT Partner to strengthen laboratories and improve medicines quality in Cambodia and Laos
- Importance of medicine quality in achieving universal health coverage (PLOS ONE)
- Applying lessons from Ebola to the COVID-19 pandemic: Strengthening African health systems while scaling up testing
- Scaling up testing for COVID-19 in Africa: Responding to the pandemic in ways that strengthen health systems (African Journal of Laboratory Medicine)
- An entire continent without medicine. Can sub-Saharan Africa produce its own drugs? (El Pais)
- A call to boost African manufacturing for COVID-19 and other vaccines
- Africa-led solutions to expedite access to COVID-19 vaccines
- The COVID catalyst: Innovating across sectors for improved access to vaccines (Devex World)
- Scaling Up African Pharmaceutical Manufacturing in a Time of COVID-19 (Council on Foreign Relations)
- COVID-19: USP offers guidance on strategic response model to African Regulatory Authorities (African Leadership Magazine)
- Low- and middle-income countries struggle with access to essential medicines (SupplyChainBrain.com)